- Home
- INO vs MRBK Comparison
INO vs MRBK Comparison
Compare INO & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | MRBK |
|---|---|---|
| Founded | 1979 | 2004 |
| Country | United States | United States |
| Employees | N/A | 322 |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6M | 198.4M |
| IPO Year | 1998 | 2017 |
Fundamental Metrics
Financial Performance| Metric | INO | MRBK |
|---|---|---|
| Price | $2.27 | $17.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $9.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.1M | 80.2K |
| Earning Date | 11-10-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | N/A | ★ 75.95 |
| EPS | N/A | ★ 1.77 |
| Revenue | $182,337.00 | ★ $109,758,000.00 |
| Revenue This Year | N/A | $26.84 |
| Revenue Next Year | $21,219.94 | $8.90 |
| P/E Ratio | ★ N/A | $9.75 |
| Revenue Growth | N/A | ★ 18.84 |
| 52 Week Low | $1.30 | $11.16 |
| 52 Week High | $4.08 | $17.43 |
Technical Indicators
Market Signals| Indicator | INO | MRBK |
|---|---|---|
| Relative Strength Index (RSI) | 59.44 | 78.25 |
| Support Level | $1.86 | $16.25 |
| Resistance Level | $2.27 | $17.43 |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 82.94 | 97.26 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.